| Identification | |
| Name: | S,S-Atorvastatin |
| CAS: | 501121-34-2 |
| Molecular Formula: | C33H34FN2NaO5 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C33H35FN2O5.Na/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;+1/p-1/t26-,27-;/m0./s1 |
| Molecular Structure: | ![(C33H34FN2NaO5) (bS,dS)-2-(4-Fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyr...](https://img.guidechem.com/structure/501121-34-2.gif) |
| Properties | |
| Specification: | White Solid usageEng:A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia |
| Usage: | A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia |
| Safety Data | |
 |
|
